Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunologic targets for breast cancer.

Mary L Disis1

  • 1Division of Oncology, University of Washington, Seattle, WA 98195-6527, USA. ndisis@u.washington.edu

Breast Disease
|February 3, 2005
PubMed
Summary

Breast cancer exhibits pre-existing immune responses against tumor proteins. Identifying and prioritizing these immunogenic antigens is crucial for developing effective breast cancer immunotherapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predicting Durable Anti-tumor Immune Responses after Cancer Vaccines.

Journal of cancer immunology·2026
Same author

Safety and immunogenicity of a tri-antigen vaccine targeting IGFBP-2, HER2, and IGF-IR in participants with non-metastatic breast cancer.

Journal for immunotherapy of cancer·2026
Same author

Towards machine learning fairness in classifying multicategory causes of deaths in colorectal or lung cancer patients.

Briefings in bioinformatics·2025
Same author

SITC strategic vision: prevention, premalignant immunity, host and environmental factors.

Journal for immunotherapy of cancer·2025
Same author

Towards machine learning fairness in classifying multicategory causes of deaths in colorectal or lung cancer patients.

bioRxiv : the preprint server for biology·2025
Same author

A Phase II Study of Denileukin Diftitox in Patients with Advanced Treatment Refractory Breast Cancer.

Vaccines·2025

Area of Science:

  • Oncology
  • Immunology
  • Genomics
  • Proteomics

Background:

  • Breast cancer is recognized as an immunogenic tumor type.
  • Patients often display pre-existing humoral and cellular immune responses against tumor-associated proteins.

Purpose of the Study:

  • To review the abundance of immunogenic proteins in breast cancer.
  • To address the challenge of prioritizing candidate antigens for clinical evaluation in immunotherapies.

Main Methods:

  • Genomic and proteomic techniques have identified numerous potential immunologic targets.
  • Directed evaluation of well-defined immunogenic breast cancer proteins.

Main Results:

  • Dozens of proteins have been identified as potential immunologic targets in breast cancer.
  • Some candidate antigens are progressing into human clinical trials for immune-based therapies.

Conclusions:

  • A wide array of immunogenic proteins are associated with breast cancer.
  • Prioritizing these antigens is the key experimental question for advancing breast cancer immunotherapy.

Related Experiment Videos